Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Accumulated Depreciation & Amortization (2016)

Historic Accumulated Depreciation & Amortization for Eledon Pharmaceuticals (ELDN) over the last 4 years, with Q4 2016 value amounting to $197000.0.

  • Eledon Pharmaceuticals' Accumulated Depreciation & Amortization rose 1939.39% to $197000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $197000.0, marking a year-over-year increase of 1939.39%. This contributed to the annual value of $197000.0 for FY2016, which is 1939.39% up from last year.
  • Latest data reveals that Eledon Pharmaceuticals reported Accumulated Depreciation & Amortization of $197000.0 as of Q4 2016, which was up 1939.39% from $165000.0 recorded in Q4 2015.
  • Eledon Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $197000.0 for Q4 2016, and its period low was $43000.0 during Q4 2013.
  • Over the past 4 years, Eledon Pharmaceuticals' median Accumulated Depreciation & Amortization value was $111500.0 (recorded in 2014), while the average stood at $115750.0.
  • In the last 5 years, Eledon Pharmaceuticals' Accumulated Depreciation & Amortization soared by 18448.28% in 2015 and then surged by 1939.39% in 2016.
  • Quarter analysis of 4 years shows Eledon Pharmaceuticals' Accumulated Depreciation & Amortization stood at $43000.0 in 2013, then soared by 34.88% to $58000.0 in 2014, then surged by 184.48% to $165000.0 in 2015, then grew by 19.39% to $197000.0 in 2016.
  • Its Accumulated Depreciation & Amortization was $197000.0 in Q4 2016, compared to $165000.0 in Q4 2015 and $58000.0 in Q4 2014.